Snehal Pharma & Surgicals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 7.29 Cr
as on 03-07-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 50.96 Cr
as on 03-07-2024
- Satisfied Charges ₹ 15.82 Cr
as on 03-07-2024
- Revenue 112.01%
(FY 2023)
- Profit 108.01%
(FY 2023)
- Ebitda 346.17%
(FY 2023)
- Net Worth 12.75%
(FY 2023)
- Total Assets -2.51%
(FY 2023)
About Snehal Pharma & Surgicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.29 Cr.
The company currently has active open charges totaling ₹50.96 Cr. The company has closed loans amounting to ₹15.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Deulgaonkar and Subodh Deulgaonkar serve as directors at the Company.
- CIN/LLPIN
U33110MH2011PTC218317
- Company No.
218317
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Snehal Pharma & Surgicals Private Limited offer?
Snehal Pharma & Surgicals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication, Diabetes Medicine, Medical Supplies, Surgical Supplies, Antiparasitic Drug, Blood Pressure Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Snehal Pharma & Surgicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Deulgaonkar  | Managing Director | 06-Jun-2011 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subodh Deulgaonkar | Director | 06-Jun-2011 | Current |
Financial Performance of Snehal Pharma & Surgicals.
Snehal Pharma & Surgicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 112.01% increase. The company also saw a substantial improvement in profitability, with a 108.01% increase in profit. The company's net worth Soared by an impressive increase of 12.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Snehal Pharma & Surgicals?
In 2023, Snehal Pharma & Surgicals had a promoter holding of 50.75% and a public holding of 49.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Snehal International Pharma Private LimitedActive 4 years 3 monthsSudhir Deulgaonkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Nagpur Nagarik Sahakari Bank Limited Creation Date: 23 Mar 2020 | ₹26.60 Cr | Open |
Nagpur Nagarik Sahakari Bank Limited Creation Date: 01 Oct 2018 | ₹17.50 Cr | Open |
Nagpur Nagarik Sahakari Bank Limited Creation Date: 13 May 2016 | ₹6.86 Cr | Open |
How Many Employees Work at Snehal Pharma & Surgicals?
Snehal Pharma & Surgicals has a workforce of 38 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Snehal Pharma & Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snehal Pharma & Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
